Drugs that contain Fentanyl Citrate

1. List of Fentora drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8092832 CEPHALON Generally linear effervescent oral fentanyl dosage form and methods of administering
Dec, 2024

(1 year, 10 months from now)

US8119158 CEPHALON Effervescent oral fentanyl dosage form and methods of administering fentanyl
Dec, 2024

(1 year, 10 months from now)

US7862833 CEPHALON Effervescent oral opiate dosage forms and methods of administering opiates
Jun, 2028

(5 years from now)

US7862832 CEPHALON Generally linear effervescent oral fentanyl dosage form and methods of administering
Jun, 2028

(5 years from now)

Market Authorisation Date: 25 September, 2006

Treatment: NA

Dosage: TABLET;BUCCAL, SUBLINGUAL

How can I launch a generic of FENTORA before it's patent expiration?
More Information on Dosage

2. List of Lazanda drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9814705 BTCP PHARMA Intranasal spray device containing pharmaceutical composition
Jan, 2024

(11 months from now)

US9078814 BTCP PHARMA Intranasal spray device containing pharmaceutical composition
Jan, 2024

(11 months from now)

US8889176 BTCP PHARMA Method of managing or treating pain
Jan, 2024

(11 months from now)

US8216604 BTCP PHARMA Method of managing or treating pain
Oct, 2024

(1 year, 7 months from now)

US9731869 BTCP PHARMA Container
Jan, 2032

(8 years from now)

Market Authorisation Date: 30 June, 2011

Treatment: Management of breakthrough pain in patients with cancer

Dosage: SPRAY, METERED;NASAL

More Information on Dosage

3. List of Onsolis drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9597288 BDSI Transmucosal delivery devices with enhanced uptake
Jul, 2027

(4 years from now)

Market Authorisation Date: 16 July, 2009

Treatment: Management of breakthrough pain in patients with cancer

Dosage: FILM;BUCCAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic